Sarepta begins enrollment for enhanced safety protocol in gene therapy study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. META
3. TSLA
4. STZ
5. HOOD
6. GOOGL
7. FDS
8. NVDA
9. FUTU
10. LMN

Go back to Sarepta begins enrollment for enhanced safety protocol in gene therapy study
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 19.19 +0.99 (5.44%)
Previous Close $18.20    52 Week High $63.73 
Open $18.41    52 Week Low $8.00 
Day High $19.56    P/E N/A 
Day Low $18.03    EPS $-5.69 
Volume 1,450,045